Literature DB >> 15749976

Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.

Lars Matuszewski1, Thorsten Persigehl, Alexander Wall, Wolfram Schwindt, Bernd Tombach, Manfred Fobker, Christopher Poremba, Wolfgang Ebert, Walter Heindel, Christoph Bremer.   

Abstract

PURPOSE: To evaluate the effect of lipofection, particle size, and surface coating on labeling efficiency of mammalian cells with superparamagnetic iron oxides (SPIOs).
MATERIALS AND METHODS: Institutional Review Board approval was not required. Different human cell lines (lung and breast cancer, fibrosarcoma, leukocytes) were tagged by using carboxydextran-coated SPIOs of various hydrodynamic diameters (17-65 nm) and a dextran-coated iron oxide (150 nm). Cells were incubated with increasing concentrations of iron (0.01-1.00 mg of iron [Fe] per milliliter), including or excluding a transfection medium (TM). Cellular iron uptake was analyzed qualitatively at light and electron microscopy and was quantified at atomic emission spectroscopy. Cell visibility was assessed with gradient- and spin-echo magnetic resonance (MR) imaging. Effects of iron concentration in the medium and of lipofection on cellular SPIO uptake were analyzed with analysis of variance and two-tailed Student t test, respectively.
RESULTS: Iron oxide uptake increased in a dose-dependent manner with higher iron concentrations in the medium. The TM significantly increased the iron load of cells (up to 2.6-fold, P < .05). For carboxydextran-coated SPIOs, larger particle size resulted in improved cellular uptake (65 nm, 4.37 microg +/- 0.08 Fe per 100 000 cells; 17 nm, 2.14 microg +/- 0.06 Fe per 100 000 cells; P < .05). Despite larger particle size, dextran-coated iron oxides did not differ from large carboxydextran-coated particles (150 nm, 3.81 microg +/- 0.46 Fe per 100 000 cells; 65 nm, 4.37 microg +/- 0.08 Fe per 100 000 cells; P > .05). As few as 10 000 cells could be detected with clinically available MR techniques by using this approach.
CONCLUSION: Lipofection-based cell tagging is a simple method for efficient cell labeling with clinically approved iron oxide-based contrast agents. Large particle size and carboxydextran coating are preferable for cell tagging with endocytosis- and lipofection-based methods. (c) RSNA, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749976     DOI: 10.1148/radiol.2351040094

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  57 in total

1.  Effect of concentration of SH U 555A labeled human melanoma cells on MR spin echo and gradient echo signal decay at 0.2, 1.5, and 3T.

Authors:  J Pintaske; R Bantleon; R Kehlbach; C D Claussen; J Wiskirchen; F Schick
Journal:  MAGMA       Date:  2006-05-16       Impact factor: 2.310

2.  Cell labeling with the positive MR contrast agent Gadofluorine M.

Authors:  Tobias D Henning; Olaf Saborowski; Daniel Golovko; Sophie Boddington; Jan S Bauer; Yanjun Fu; Reinhard Meier; Hubertus Pietsch; Barbara Sennino; Donald M McDonald; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

Review 3.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

Review 4.  Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors:  Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

5.  Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles.

Authors:  Ambros J Beer; Konstantin Holzapfel; Juliana Neudorfer; Guido Piontek; Marcus Settles; Holger Krönig; Christian Peschel; Jürgen Schlegel; Ernst J Rummeny; Helga Bernhard
Journal:  Eur Radiol       Date:  2008-02-20       Impact factor: 5.315

6.  Superparamagnetic iron oxide labeling of neural stem cells and 4.7T MRI tracking in vivo and in vitro.

Authors:  Wenzhen Zhu; Xiang Li; Zhouping Tang; Suiqiang Zhu; Jianpin Qi; Li Wei; Hao Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-02

7.  Superparamagnetic iron oxide labeling of spinal cord neural stem cells genetically modified by nerve growth factor-beta.

Authors:  Deqiang Lei; Hongyang Zhao; Xingli Deng; Ruen Liu; Fangcheng Zhang; Dongxiao Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

8.  Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.

Authors:  Daniel L J Thorek; Andrew Tsourkas
Journal:  Biomaterials       Date:  2008-06-03       Impact factor: 12.479

Review 9.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

10.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.